Canada markets open in 9 hours 9 minutes

Beximco Pharmaceuticals Limited (R2WA.SG)

Stuttgart - Stuttgart Delayed Price. Currency in EUR
Add to watchlist
0.3980-0.0020 (-0.50%)
At close: 08:18AM CEST
Currency in EUR

Valuation Measures4

Market Cap (intraday) 447.33M
Enterprise Value 498.16M
Trailing P/E 4.00
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.49
Price/Book (mrq)0.46
Enterprise Value/Revenue 0.01
Enterprise Value/EBITDA 0.06

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-5.21%
S&P500 52-Week Change 321.33%
52 Week High 30.5000
52 Week Low 30.3700
50-Day Moving Average 30.4262
200-Day Moving Average 30.4326

Share Statistics

Avg Vol (3 month) 3961
Avg Vol (10 day) 31.2k
Shares Outstanding 5446.11M
Implied Shares Outstanding 61.12B
Float 8297.32M
% Held by Insiders 10.00%
% Held by Institutions 11.72%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 40.03
Forward Annual Dividend Yield 47.37%
Trailing Annual Dividend Rate 33.50
Trailing Annual Dividend Yield 3875.00%
5 Year Average Dividend Yield 44.06
Payout Ratio 429.75%
Dividend Date 3N/A
Ex-Dividend Date 4Nov 10, 2023
Last Split Factor 21.1:1
Last Split Date 3Nov 23, 2020

Financial Highlights

Currency in BDT.

Fiscal Year

Fiscal Year Ends Jun 30, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 12.37%
Operating Margin (ttm)17.20%

Management Effectiveness

Return on Assets (ttm)6.97%
Return on Equity (ttm)10.99%

Income Statement

Revenue (ttm)43.08B
Revenue Per Share (ttm)96.58
Quarterly Revenue Growth (yoy)15.00%
Gross Profit (ttm)N/A
EBITDA 9.43B
Net Income Avi to Common (ttm)5.33B
Diluted EPS (ttm)0.1000
Quarterly Earnings Growth (yoy)43.50%

Balance Sheet

Total Cash (mrq)1.36B
Total Cash Per Share (mrq)3.05
Total Debt (mrq)7.43B
Total Debt/Equity (mrq)14.73%
Current Ratio (mrq)1.80
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)8.37B
Levered Free Cash Flow (ttm)2.57B